B-Type Natriuretic Peptide Assay for the Diagnosis and Prognosis of Patent Ductus Arteriosus in Preterm Infants

BACKGROUND AND OBJECTIVES: Patent ductus arteriosus (PDA) is a significant cause of morbidity and mortality in preterm infants. Measurement of plasma B-type natriuretic peptide (BNP) has been reported to be a useful bedside screening tool for the presence of hemodynamically significant PDA (hsPDA) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Joon Sik, Shim, Eun Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318091/
https://www.ncbi.nlm.nih.gov/pubmed/22493614
http://dx.doi.org/10.4070/kcj.2012.42.3.192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318091/
https://www.ncbi.nlm.nih.gov/pubmed/22493614
http://dx.doi.org/10.4070/kcj.2012.42.3.192

Ejemplares similares